SE7408141L - - Google Patents
Info
- Publication number
- SE7408141L SE7408141L SE7408141A SE7408141A SE7408141L SE 7408141 L SE7408141 L SE 7408141L SE 7408141 A SE7408141 A SE 7408141A SE 7408141 A SE7408141 A SE 7408141A SE 7408141 L SE7408141 L SE 7408141L
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3699970A | 1970-05-13 | 1970-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7408141L true SE7408141L (xx) | 1974-06-19 |
Family
ID=21891894
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7408141A SE389739B (sv) | 1970-05-13 | 1971-05-13 | Sett att pavisa opiumalkaloider |
| SE7106271A SE389737B (sv) | 1970-05-13 | 1971-05-13 | Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset |
| SE7408141A SE7408141L (xx) | 1970-05-13 | 1974-06-19 | |
| SE7408140A SE417970B (sv) | 1970-05-13 | 1974-06-19 | Opiumalkaloidantigen till anvendning vid framstellning av en antikropp som kan utnyttjas vid immunanalys av opiumalkaloiden i biologisk vetska |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7408141A SE389739B (sv) | 1970-05-13 | 1971-05-13 | Sett att pavisa opiumalkaloider |
| SE7106271A SE389737B (sv) | 1970-05-13 | 1971-05-13 | Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7408140A SE417970B (sv) | 1970-05-13 | 1974-06-19 | Opiumalkaloidantigen till anvendning vid framstellning av en antikropp som kan utnyttjas vid immunanalys av opiumalkaloiden i biologisk vetska |
Country Status (5)
| Country | Link |
|---|---|
| CA (1) | CA966778A (xx) |
| DE (1) | DE2166716C3 (xx) |
| DK (1) | DK142145B (xx) |
| GB (1) | GB1320056A (xx) |
| SE (4) | SE389739B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104367A (en) * | 1976-10-13 | 1978-08-01 | Hoffmann-La Roche Inc. | Radioimmunoassay for methadone |
| CN113968853B (zh) * | 2020-07-22 | 2022-09-16 | 中国农业大学 | 阿托品类生物碱的半抗原、人工抗原及其制备方法与应用 |
-
1971
- 1971-05-11 DE DE2166716A patent/DE2166716C3/de not_active Expired
- 1971-05-12 CA CA112,764A patent/CA966778A/en not_active Expired
- 1971-05-12 DK DK228271AA patent/DK142145B/da unknown
- 1971-05-13 SE SE7408141A patent/SE389739B/xx not_active IP Right Cessation
- 1971-05-13 GB GB1462971*[A patent/GB1320056A/en not_active Expired
- 1971-05-13 SE SE7106271A patent/SE389737B/xx unknown
-
1974
- 1974-06-19 SE SE7408141A patent/SE7408141L/xx unknown
- 1974-06-19 SE SE7408140A patent/SE417970B/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK142145B (da) | 1980-09-08 |
| CA966778A (en) | 1975-04-29 |
| SE389737B (sv) | 1976-11-15 |
| SE7408140L (xx) | 1974-06-19 |
| DE2123300B2 (de) | 1976-03-04 |
| GB1320056A (en) | 1973-06-13 |
| SE417970B (sv) | 1981-04-27 |
| DK142145C (xx) | 1981-02-02 |
| DE2166716B2 (de) | 1979-09-27 |
| DE2166716A1 (de) | 1975-04-24 |
| SE389739B (sv) | 1976-11-15 |
| DE2123300A1 (de) | 1971-11-25 |
| DE2166716C3 (de) | 1980-06-12 |